awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36937081-09E41FF2-0BA0-431B-A001-55D26373F683
Q36937081-09E41FF2-0BA0-431B-A001-55D26373F683
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36937081-09E41FF2-0BA0-431B-A001-55D26373F683
A long-term surviving patient with recurrent low-grade serous ovarian carcinoma treated with the MEK1/2 inhibitor, selumetinib.
P2860
Q36937081-09E41FF2-0BA0-431B-A001-55D26373F683
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36937081-09E41FF2-0BA0-431B-A001-55D26373F683
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
de012e646f3b19d0ed6bbdf4a076b94105d6febc
P2860
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.